CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: astilbin
Accession: CHEBI:38200
browse the term
Definition: A flavanone glycoside that is (+)-taxifolin substituted by a alpha-L-rhamnosyl moiety at position 3 via a glycosidic linkage.
Synonyms: exact_synonym: (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-4-oxo-3,4-dihydro-2H-chromen-3-yl 6-deoxy-alpha-L-mannopyranoside
related_synonym: (2R,3R)-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-3,4-dihydro-2H-1-benzopyran-4-one; (2R,3R)-3-[(6-deoxy-alpha-L-mannopyranosyl)oxy]-2-(3,4-dihydroxyphenyl)-2,3-dihydro-5,7-dihydroxy-4H-1-benzopyran-4-one; Formula=C21H22O11; InChI=1S/C21H22O11/c1-7-15(26)17(28)18(29)21(30-7)32-20-16(27)14-12(25)5-9(22)6-13(14)31-19(20)8-2-3-10(23)11(24)4-8/h2-7,15,17-26,28-29H,1H3/t7-,15-,17+,18+,19+,20-,21-/m0/s1; InChIKey=ZROGCCBNZBKLEL-MPRHSVQHSA-N; SMILES=C[C@@H]1O[C@@H](O[C@@H]2[C@H](Oc3cc(O)cc(O)c3C2=O)c2ccc(O)c(O)c2)[C@H](O)[C@H](O)[C@H]1O; dihydroquercetin-3-O-alpha-LRhap
xref: Beilstein:100564; CAS:29838-67-3; HMDB:HMDB0033850
xref_mesh: MESH:C099069
xref: PMID:21157633; PMID:21476602; PMID:21600261; PMID:21614752; Reaxys:100564; Wikipedia:Astilbin
cyclic_relationship: is_enantiomer_of CHEBI:27669
G
Akr1c1
aldo-keto reductase family 1, member C1
multiple interactions
ISO
[astilbin co-treated with Cisplatin] results in increased expression of AKR1C1 mRNA
CTD
PMID:29471006
NCBI chr17:65,810,474...65,837,385
Ensembl chr17:65,810,475...65,837,326
G
Akt1
AKT serine/threonine kinase 1
multiple interactions
ISO
astilbin inhibits the reaction [Cisplatin results in decreased phosphorylation of AKT1 protein]
CTD
PMID:29471006
NCBI chr 6:131,713,716...131,735,319
Ensembl chr 6:131,713,720...131,733,921
G
Bax
BCL2 associated X, apoptosis regulator
multiple interactions
ISO
astilbin inhibits the reaction [Cisplatin results in increased expression of BAX protein]
CTD
PMID:29471006
NCBI chr 1:95,940,001...95,945,407
Ensembl chr 1:95,938,808...95,945,368
G
Bcl2
BCL2, apoptosis regulator
multiple interactions
ISO
astilbin inhibits the reaction [Cisplatin results in decreased expression of BCL2 protein]
CTD
PMID:29471006
NCBI chr13:22,689,783...22,853,920
Ensembl chr13:22,684,989...22,853,743 Ensembl chr13:22,684,989...22,853,743
G
Casp3
caspase 3
multiple interactions
ISO
astilbin inhibits the reaction [Cisplatin results in increased cleavage of CASP3 protein]
CTD
PMID:29471006
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
G
Casp9
caspase 9
multiple interactions
ISO
astilbin inhibits the reaction [Cisplatin results in increased cleavage of CASP9 protein]
CTD
PMID:29471006
NCBI chr 5:154,108,872...154,126,628
Ensembl chr 5:154,109,046...154,126,626
G
Cat
catalase
multiple interactions
ISO
astilbin inhibits the reaction [Cisplatin results in decreased activity of CAT protein]
CTD
PMID:29471006
NCBI chr 3:89,842,393...89,874,577
Ensembl chr 3:89,842,399...89,874,478
G
Gclc
glutamate-cysteine ligase, catalytic subunit
multiple interactions
ISO
astilbin inhibits the reaction [Cisplatin results in decreased expression of GCLC mRNA]
CTD
PMID:29471006
NCBI chr 8:78,629,899...78,668,547
Ensembl chr 8:78,630,127...78,668,544
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions
ISO
astilbin promotes the reaction [Cisplatin results in increased expression of GCLM mRNA]
CTD
PMID:29471006
NCBI chr 2:210,347,482...210,367,537
Ensembl chr 2:210,347,482...210,367,535
G
Il1b
interleukin 1 beta
multiple interactions
ISO
astilbin inhibits the reaction [Cisplatin results in increased expression of IL1B protein]
CTD
PMID:29471006
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
G
Il6
interleukin 6
multiple interactions
ISO
astilbin inhibits the reaction [Cisplatin results in increased expression of IL6 protein]
CTD
PMID:29471006
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
G
Mapk1
mitogen activated protein kinase 1
multiple interactions
ISO
astilbin inhibits the reaction [Cisplatin results in increased phosphorylation of MAPK1 protein]
CTD
PMID:29471006
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
G
Mapk3
mitogen activated protein kinase 3
multiple interactions
ISO
astilbin inhibits the reaction [Cisplatin results in increased phosphorylation of MAPK3 protein]
CTD
PMID:29471006
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
G
Nfe2l2
NFE2 like bZIP transcription factor 2
multiple interactions
ISO
astilbin promotes the reaction [Cisplatin affects the localization of NFE2L2 protein] astilbin promotes the reaction [Cisplatin results in increased expression of NFE2L2 protein]
CTD
PMID:29471006
NCBI chr 3:60,594,239...60,621,712
Ensembl chr 3:60,594,242...60,621,737
G
Nfkbia
NFKB inhibitor alpha
multiple interactions
ISO
astilbin inhibits the reaction [Cisplatin results in increased phosphorylation of NFKBIA protein]
CTD
PMID:29471006
NCBI chr 6:72,858,713...72,861,941
Ensembl chr 6:72,858,712...72,861,941
G
Nos2
nitric oxide synthase 2
multiple interactions
ISO
astilbin inhibits the reaction [Cisplatin results in increased expression of NOS2 protein]
CTD
PMID:29471006
NCBI chr10:63,815,308...63,851,208
Ensembl chr10:63,815,308...63,851,210
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
ISO
astilbin promotes the reaction [Cisplatin results in increased expression of NQO1 mRNA]
CTD
PMID:29471006
NCBI chr19:35,295,633...35,310,528
Ensembl chr19:35,295,573...35,310,557
G
Parp1
poly (ADP-ribose) polymerase 1
multiple interactions
ISO
astilbin inhibits the reaction [Cisplatin results in increased cleavage of PARP1 protein]
CTD
PMID:29471006
NCBI chr13:92,307,593...92,339,406
Ensembl chr13:92,307,586...92,339,404
G
Ptgs2
prostaglandin-endoperoxide synthase 2
multiple interactions
ISO
astilbin inhibits the reaction [Cisplatin results in increased expression of PTGS2 protein]
CTD
PMID:29471006
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
G
Rela
RELA proto-oncogene, NF-kB subunit
multiple interactions
ISO
astilbin inhibits the reaction [Cisplatin results in increased phosphorylation of RELA protein]
CTD
PMID:29471006
NCBI chr 1:202,925,001...202,935,484
Ensembl chr 1:202,924,945...202,935,484
G
Tnf
tumor necrosis factor
multiple interactions
ISO
astilbin promotes the reaction [Cisplatin results in increased expression of TNF mRNA] astilbin inhibits the reaction [Cisplatin results in increased expression of TNF protein]
CTD
PMID:29471006
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
G
Tp53
tumor protein p53
multiple interactions
ISO
astilbin inhibits the reaction [Cisplatin results in increased expression of TP53 protein]
CTD
PMID:29471006
NCBI chr10:54,300,070...54,311,525
Ensembl chr10:54,300,048...54,311,524
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all